KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Vir Biotechnology (VIR) Amortization - Intangibles (2020 - 2024)

Vir Biotechnology's Amortization - Intangibles history spans 5 years, with the latest figure at $18.8 million for Q2 2024.

  • On a quarterly basis, Amortization - Intangibles fell 18.12% to $18.8 million in Q2 2024 year-over-year; TTM through Jun 2024 was $82.8 million, a 18.57% increase, with the full-year FY2023 number at $87.0 million, up 209.66% from a year prior.
  • Amortization - Intangibles hit $18.8 million in Q2 2024 for Vir Biotechnology, down from $21.3 million in the prior quarter.
  • Over the last five years, Amortization - Intangibles for VIR hit a ceiling of $23.0 million in Q2 2023 and a floor of $11000.0 in Q3 2021.
  • Historically, Amortization - Intangibles has averaged $8.8 million across 5 years, with a median of $2.0 million in 2020.
  • Biggest five-year swings in Amortization - Intangibles: crashed 97.33% in 2021 and later skyrocketed 84736.36% in 2022.
  • Tracing VIR's Amortization - Intangibles over 5 years: stood at $288000.0 in 2020, then tumbled by 42.01% to $167000.0 in 2021, then soared by 9583.83% to $16.2 million in 2022, then increased by 28.22% to $20.7 million in 2023, then decreased by 9.11% to $18.8 million in 2024.
  • Business Quant data shows Amortization - Intangibles for VIR at $18.8 million in Q2 2024, $21.3 million in Q1 2024, and $20.7 million in Q4 2023.